Other liquid samples, Serum, Cell culture supernatants, Plasma, Cell lysate
Assay Type
Qualitative
Recovery
Matrices listed below were spiked with certain level of Anti-2019 nCoV(S) IgG and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-2019 nCoV(S) IgG in samples.
Matrix
Recovery range(%)
Average(%)
serum(n=5)
89-104
99
EDTA plasma(n=5)
90-98
95
heparin plasma(n=5)
91-97
94
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-2019 nCoV(S) IgG and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample
1:2
1:4
1:8
serum(n=5)
87-98%
85-101%
87-104%
EDTA plasma(n=5)
86-100%
85-96%
83-100%
heparin plasma(n=5)
80-100%
80-100%
80-100%
Sensitivity
< Qualitative
Notes
For Research Use Only
Applications
ELISA
Applications Notes
Anti-2019 nCoV IgG ELISA Kit allows for the in vitro quantitative determination of Anti-2019 nCoV(S) IgG concentrations in serum, plasma, tissue homogenates and other biological fluids.